Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy Life Science Investing
Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus' Proprietary Safety Switch System Pharmaceutical Investing
Lobe Sciences Announces the Expansion of its Patent Portfolio with International Filings Pharmaceutical Investing
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference Pharmaceutical Investing
Kite Receives U.S. FDA Approval of Viral Vector Manufacturing Facility in Southern California to Produce Commercial Product Pharmaceutical Investing
SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY Pharmaceutical Investing
Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial Company News
Cardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosis Pharmaceutical Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
